OBI forfeits subscription of AP Biosciences’ cash capital increase, distributes rights to its shareholders and sets target date

1.Date of occurrence of the event:2022/08/08
2.Company name:OBI Pharma Inc.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:Not applicable
5.Cause of occurrence:To be conducted by the Board of Directors’ resolution on 2022/08/08.
6.Countermeasures:None
7.Any other matters that need to be specified:
(1)The Company decides to forfeit all the preemptive rights of AP Biosciences’ cash capital increase and distribute the rights to shareholders of OBI. The issue price is expected to be NT$50 per share, with each thousand shares of OBI bearing the subscription rights for 34.3016 shares of AP Biosciences. The forfeiture is approved by the Company’s Board of Directors on 2022/08/08.
(2)To coordinate with AP Bioscience’ schedule of the reference date of cash capital increase, the reference date for shareholders of OBI to subscribe the new shares is announced as follows:
A.The target date of distribution of other benefits of the Company:2022/08/28
B.The book closure period of the Company:2022/08/24~2022/08/28
C.Last date before book closure of the Company:2022/08/23
D.Ex-rights date of the Company:2022/08/22
E.Payment period of the Company:2022/08/30~2022/09/06
The subscription rights may not be transferred. Once the period of existence expires, shareholders may no longer claim his or her subscription rights to subscribe for shares.
F.The reference date of cash capital increase of AP Bioscience:2022/10/4 (tentatively)
(3)To coordinate with stock affairs of AP Bioscience, share subscription form will be sent through registered mail to shareholders whose available shares based on the shareholding ratio stated on the register of shareholders on the book closure date exceed one thousand shares. Other shareholders whose available shares are less than one thousand shares will be notified only by announcement. For shareholders who do not receive the share subscription form, please contact transfer agent of AP Biosciences for payment information.
Masterlink Securities
TEL:(02)2768-6668
Address:B1., No. 35, Ln. 11, Guangfu N. Rd., Songshan Dist., Taipei City, Taiwan.
(4)The Chairman was authorized to decide change of the schedule, or any other matters not covered herein.